Koyfin Home > Directory > Health Care > Acorda Therapeutics > Total Equity

Acorda Therapeutics Total Equity Chart (ACOR)

Acorda Therapeutics annual/quarterly Total Equity from 2010 to 2020.
  • Acorda Therapeutics Total Equity for the quarter ending June 06, 2020 was $291m a 3.29% increase of 10m year over year
  • Acorda Therapeutics Total Equity for the last 12 months ending June 06, 2020 was $291m a 3.29% increase of 10m year over year
  • Acorda Therapeutics Annual Total Equity for 2019 was $311m a -96.89% decrease of -301m from 2018
  • Acorda Therapeutics Annual Total Equity for 2018 was $612m a 15.03% increase of 92m from 2017
  • Acorda Therapeutics Annual Total Equity for 2017 was $520m a -27.74% decrease of -144m from 2016
Other Balance Sheet Metrics:
  • Acorda Therapeutics Total Assets for the quarter ending December 12, 2018 was $1,300m a 8.66% increase of 113m year over year
  • Acorda Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $204m a 10.59% increase of 22m year over year
View Chart On Koyfin

Quarterly ACOR Total Equity Data

06/2020$291m
03/2020$307m
12/2019$311m
09/2019$281m
06/2019$545m
03/2019$567m
12/2018$612m
09/2018$599m
06/2018$607m
03/2018$550m

Annual ACOR Total Equity Data

2019$311m
2018$612m
2017$520m
2016$664m
2015$603m
2014$540m
2013$440m
2012$386m
2011$205m
2010$151m